N-Phenyltrifluoromethanesulfonimide

We are N-Phenyltrifluoromethanesulfonimide CAS:37595-74-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: N-Phenyltrifluoromethanesulfonimide
Other Name: Phenyl Triflimide;N,N-Bis(trifluoromethylsulfonyl)aniline;N,N-Bis(trifluoromethylsulfonyl)phenylamine
CAS No: 37595-74-7
MF: C8H5F6NO4S2
MW: 357.25000
Density: 1.766 g/cm3
Boiling point: 305.3ºC at 760 mmHg
Melting point: 100-102 °C(lit.)
Flash point: 138.4ºC
Refractive index: 1.488
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White to off-white crystalline powder
Assay: ≥98%
N-Phenyltrifluoromethanesulphonamide: ≦0.2%
Aniline: ≦0.5%
Other impurity: ≦1%
 
Application
It is a highly efficient trifluoromethanesulfonylation reagent, which is commonly used for the selective trifluoromethanesulfonylation of phenols, primary amines and enols.
It is widely used in the synthesis of drugs, pesticides, sugars and proteins.
 
Package: 25kg/drum
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N-Phenyltrifluoromethanesulfonimide


Related News: Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.143382-03-0 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.115-46-8 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.4-Amino-3-fluoropyridine The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.

Related Products
Product Name
tert-butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate View Details
Fluoro-N,N,N’,N’-tetramethylformamidinium hexafluorophosphate View Details
Poly(dimethylsiloxane) hydride terminated View Details
ADENOSINE5′-MONOPHOSPHATESODIUMSALT manufacturer 2-Butyn-1-ol manufacturer ethyl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate manufacturer (1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine manufacturer FMOC-S-trityl-L-cysteine manufacturer